A. Dona'

Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells

S. Andò, D. Bonofiglio, M. Pellegrino, 2016, Oncotarget.

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

C. Hofmeister, A. Krishnan, F. Pichiorri, 2021, Molecular therapy oncolytics.

Bergapten induces metabolic reprogramming in breast cancer cells.

E. Cione, S. Aquila, D. Sisci, 2016, Oncology reports.

FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

C. Giordano, D. Bonofiglio, F. Sotgia, 2019, Cancers.

MiR-16 regulates crosstalk in NF-kB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages.

J. Keats, P. L. Bergsagel, C. Hofmeister, 2019, JCI insight.

Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.

F. Pichiorri, L. Gambini, A. Salem, 2018, Journal of medicinal chemistry.

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor

S. Andò, M. Pellegrino, P. Rizza, 2016, Oncotarget.